North America Silent Heart Attack Market to Reach $4.0 Billion by 2035

North America silent attack market was valued at $2.0 billion in 2025 and is projected to reach $4.0 billion by 2035, growing at a CAGR of 7.3% from 2026 to 2035. Market growth is primarily driven by the increasing burden of cardiovascular diseases and the rising need for early and accurate diagnosis of asymptomatic cardiac conditions. According to the World Health Organization, cardiovascular diseases remain the leading cause of death globally, accounting for nearly 17.9 million casualties annually. The report also emphasized that many cardiovascular conditions, including heart attacks, can occur without symptoms, underscoring the need for early detection technologies. In North America, the growing adoption of high-sensitivity troponin testing, AI-enabled imaging, and wearable cardiac monitoring devices is significantly improving early detection of silent myocardial infarctions. Additionally, increasing healthcare expenditure and strong infrastructure across hospitals and diagnostic centers are accelerating the integration of advanced cardiac diagnostic solutions.

Browse the full report description of “North America Silent Heart Attack Market Size, Share & Trends Analysis Report by Diagnostic (Electrocardiogram (ECG), Cardiac Biomarkers Testing, Cardiac Imaging, Wearable & Remote Monitoring Devices), by Treatment Type (Pharmacological Treatment, Interventional Procedures, Lifestyle & Preventive Management), by End-User (Hospitals, Cardiology Clinics, Diagnostic Centers, Homecare Settings), and Forecast Period (2026–2035)” at https://www.omrglobal.com/industry-reports/north-american-silent-heart-attack-market

Competitive Landscape of the North America Silent Attack Market

The key players in the North America Silent Heart Attack market include top companies such as Abbott Laboratories, Medtronic, Siemens Healthineers, Danaher, and Philips Healthcare, among others. The market is witnessing strong growth driven by increasing awareness of silent myocardial infarction and rapid advancements in diagnostic technologies. Hospitals and cardiology clinics are increasingly adopting continuous cardiac monitoring and biomarker-based diagnostic solutions to improve early detection rates. Additionally, the growing penetration of wearable and remote monitoring devices is transforming preventive cardiac care and enabling real-time patient monitoring across home care settings.

• In April 2026, Medtronic completed the acquisition of CathWorks for approximately $585 million to strengthen its cardiovascular diagnostics portfolio. The deal adds AI-powered technology for assessing coronary artery disease, improving early detection and treatment decisions. This advancement supports better identification of hidden cardiac conditions, including silent heart attacks, particularly across major markets like North America.

• In April 2026, GE HealthCare launched its AI-powered Imaging 360 solution to enhance operational efficiency across healthcare systems. The platform enables standardized imaging protocols, reduces workflow disruptions, and improves consistency in patient care. Although it strengthens imaging infrastructure, its impact on the North American Silent Heart Attack Market is indirect, mainly through improved diagnostic workflows rather than targeted cardiac detection.

Market Coverage

• The market number available for – 2025–2035
• Base year- 2025
• Forecast period- 2026–2035
• Segment Covered-

• By Diagnostic
• By Treatment Type
• By End User
• Competitive Landscape: Abbott Laboratories, Medtronic, Siemens Healthineers, Danaher, and Philips Healthcare, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

North America Silent Heart Attack Market Report Segment

By Diagnostic

• Electrocardiogram (ECG)
• Cardiac Biomarkers Testing (Troponin, CK-MB)
• Cardiac Imaging
• Wearable & Remote Monitoring Devices

By Treatment Type

• Pharmacological Treatment
• Interventional Procedures
• Lifestyle & Preventive Management

By End User

• Hospitals
• Cardiology Clinics
• Diagnostic Centers
• Homecare Settings

North America Silent Heart Attack Market Report Segment by Country

• US
• Canada

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/north-american-silent-heart-attack-market